Amgen 4th quarter profit tops Street estimates as costs fall

Jan 28 (Reuters) - Amgen Inc on Thursday reported much higher-than-expected fourth-quarter earnings, helped by increased sales of its blockbuster rheumatoid arthritis drug Enbrel and lower costs, and the company raised its 2016 profit forecast.